lifestyle.forkstofeet.com

Author: ImmunoBrain Checkpoint Inc.

ImmunoBrain Presents Clinical Data for First Immune Checkpoint Therapy Approach in Alzheimer’s Disease at AD/PD™ 2026

March 19, 2026
ImmunoBrain to Present Topline Phase 1b Clinical Data for Immune Checkpoint Treatment in Alzheimer’s Disease at AD/PD™ 2026

March 12, 2026
Pioneering Physician-Scientist Dr. Francis S. Collins Joins ImmunoBrain Board of Directors

October 22, 2025